Humacyte, Inc. (HUMA) Free cash flow 2020–2025
Humacyte, Inc. (HUMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$105.9MFY2025 · since FY2020: -$55.9M → -$105.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.9M | -6.3% |
| FY2024 | -$99.7M | -31.9% |
| FY2023 | -$75.6M | -4.7% |
| FY2022 | -$72.2M | +11.3% |
| FY2021 | -$81.4M | -45.7% |
| FY2020 | -$55.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice